Literature DB >> 22353624

Comparison of plasma active glucagon-like peptide-1 (GLP-1) levels assayed with or without plasma extraction in non-diabetic men.

Kiyomi Masuda1, Kazutaka Aoki, Yasuo Terauchi.   

Abstract

Recently, interference from cross-reacting peptides in plasma has been recognized as being responsible for inter-subject differences in active glucagon-like peptide-1 (GLP-1) values. An ethanol or solid-phase extraction step could reduce such interference. A working group of the Japan Diabetes Society now recommends the inclusion of an extraction step when measuring active GLP-1 values. We measured the active GLP-1 levels of 200 specimens derived from 10 subjects using both methods and compared the results. The active GLP-1 levels measured by extraction method for 169 specimens with values greater than 2.0 pM tended to be lower than those by direct method. However, the correlation between the GLP-1 levels measured by extraction and direct method was r=0.9225 (p < 0.0001). In one case, the active GLP-1 level obtained using the extraction method was significantly lower than that obtained using the direct method. Therefore, though there is a good correlation between the two methods, extraction is recommended for more accurate active GLP-1 measurements.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353624     DOI: 10.1507/endocrj.ej12-0009

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  2 in total

1.  Is ghrelin a glucagon-like peptide-1 secretagogue?

Authors:  Hiroaki Ueno; Masamitsu Nakazato
Journal:  J Diabetes Investig       Date:  2015-11-05       Impact factor: 4.232

2.  Solid-phase extraction treatment is required for measurement of active glucagon-like peptide-1 by enzyme-linked immunosorbent assay kit affected by heterophilic antibodies.

Authors:  Tomonori Hasegawa; Miho Komagata; Akihiro Hamasaki; Norio Harada; Yutaka Seino; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2018-08-20       Impact factor: 4.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.